EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS139-36092 
Organism
Homo sapiens 
Tissue/cell
Myotube 
Coordinate
chr22:50977490-50978550 
TF binding sites/motifs
Number: 1             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
SPI1MA0080.4chr22:50978256-50978270CAAATGAGGAAGTT+6.2
Number of super-enhancer constituents: 15             
IDCoordinateTissue/cell
SE_09284chr22:50962266-50984180CD14
SE_10303chr22:50976142-50981548CD19_Primary
SE_12149chr22:50976365-50979505CD3
SE_15697chr22:50977089-50979202CD4_Memory_Primary_8pool
SE_16680chr22:50977026-50979996CD4_Naive_Primary_8pool
SE_17170chr22:50977410-50979736CD4p_CD225int_CD127p_Tmem
SE_19817chr22:50976234-50979106CD4p_CD25-_Il17p_PMAstim_Th17
SE_20245chr22:50975958-50981507CD56
SE_22888chr22:50976309-50979849CD8_primiary
SE_24088chr22:50977540-50978177Colon_Crypt_2
SE_24088chr22:50978245-50978494Colon_Crypt_2
SE_32587chr22:50975665-50981796GM12878
SE_54281chr22:50975745-50983790Spleen
SE_55398chr22:50977549-50978167Thymus
SE_61372chr22:50967164-50985051HBL1
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr225097795550978429
Number: 1             
IDChromosomeStartEnd
GH22I050536chr225097523150988958
Enhancer Sequence
TGGGCAACAG AGCCAGACTC CATCTCAAAA AAGAAATAAA TAAAAATAAA AATAAAAAAT 60
AAAATGTTAT AGGAACACAG CCACATCCTT TTATTTTTTA AGGTTGGTTT TGTGCAGACT 120
TGAGTAGTTG CAAGAGACTG TGTGACCTGC AGAGGCAAAA ACAGCCGCAA TCCAGCTCTT 180
CGCACAAAAA CTTTGCTGCC CCTGACTGAG GGTGTGCACG TGGGTAAAGA GCCCCAGGGC 240
CCTGCAGTAC TCCCGGGCTG GAGACGTGGC AGAAACAAGC ACTCTGATAT GTGGATCATA 300
AACAAGTGAC AGCCTCCGAC GCTCAGCACT TAGGCGTCTC AGCCAACTTT CATGAGTTAG 360
GTTGTGGGAT GTTTGATAAG TGTAGCTTCT CAAGTTTCTG TCATCCTCAC CAGGGACCCT 420
TAAGCTGGTG GACTCGTATT TGACATCTGC GGTGAGGTCC TGTTGTATTC CAGGAAGACT 480
TAATTTTCCA GACTATAATA GATTACTGTG AAACCCCAGC ATAATTACCT TACCTGAGCT 540
AAATATTAAA ATAGAGACCA GGCCTGAAGA ACCCCTGAGC AGACAAAACC AGTTAGGCGT 600
TCTAACTGAC CTCAACCTTG CCTAAATGGA AAACGTAAGT GAAACTTAAC TGGAGTCATT 660
TCTGATAAAT GGTTATGTGA GGCAGAAGTA AAACTCAACT CCAGCCAATC CTAAGCGGCC 720
AGCTAACGCT CAATTGCGTA ACTAGGGACT TCCCAACTAG ACAGACCAAA TGAGGAAGTT 780
GCATAACTGT AACCAAGTGA TTTCTTCAGT GTGCCTCCTG ATTTTCTTAA ATAGACAGAC 840
AAATACTTAT CTCTGACATT TTTGTCACTA GCCTGAGAAA AAAAGTGTTT ATGGCCAGGC 900
TCACACCTGT AATCCCAGCA CTTTGGGAGG CCGAGGTGGG TGGATTACTA GGAGTTCAAG 960
ACCAGACTGG CCAACATGGA GAAAGCCCAT CTTTACTAAA AATACAAAAA TTAGCTGGGT 1020
GTGATGGCGC GTACCTGTAA TCCCAGCTAC TCGGGAGGCT 1060